“ShcA-coupled Tyrosine Kinase Signalling Integrates Immune Suppression and Metabolic Reprogramming to Promote Cancer Progression”

When: November 22, 2016, 4-5 p.m.

Where: At the Research Institute of the McGill University Health Centre (RI-MUHC) Glen Site, RI Auditorium, E.S1-1129, 1001 Decarie Boulevard, Montreal, Quebec H4A 3J1

Guest Speaker:
Dr. Josie Ursini-Siegel
Investigator, Lady Davis Institute
Assistant Professor, Department of Oncology, McGill University

Presentations will be in English
For more information please contact: veronica.atehortua@muhc.mcgill.ca